We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
AECOM (ACM) to Spin Off Government Services Unit, Shares Up
Read MoreHide Full Article
AECOM (ACM - Free Report) announced that the board of directors has approved a plan to spin off the Management Services (“MS”) line of business into a separate government services company. The transaction, which is expected to be completed by the second half of fiscal 2020, will position AECOM’s industry-leading businesses for long-term strategic and financial growth. Notably, the company’s shares jumped more than 5% post the announcement of the news.
Benefits From This Transformational Initiative
The spin-off is part of AECOM’s ongoing transformational initiatives. It has been undertaking various strategic actions, including $225-million General and Administrative (G&A) reduction plan, to maximize shareholder value. It has initiated plans of exiting hard-bid at-risk construction and non-core Oil & Gas and fixed-price combined-cycle gas power plant construction businesses. Also, it has contemplated exit from more than 30 countries and to no longer pursue international at-risk construction opportunities.
Post the spin-off, AECOM is expected to benefit from high-returning professional services businesses, strong cash flow, solid return of capital to its shareholders and debt reduction under the existing capital allocation policy.
Per the plan, both the companies are likely to benefit from strong management teams, with primary focus on their respective businesses, and separate boards of directors’ proficiency.
the company revealed that the new public company will be ranked among top 20 government service providers, as ranked by Bloomberg. The new entity will continue to leverage its extensive intelligence, cybersecurity, IT, nuclear remediation and O&M expertise to provide value and best-of-class services, primarily to various government agencies.
The company will be well placed to execute strategic plans for expanding its capabilities and pursuing more than $30 billion pipeline of opportunities. The business will be fortified with several key competitive advantages, including scale in a fragmented market, strong execution of pipeline contracts, and more than 25,000 talented and committed employees.
AECOM Inks Agreement With Toshiba; Fortifies MS Business
In a separate release, AECOM unveiled that it has signed an Alliance Agreement with Toshiba to work together on decommissioning nuclear reactors in Japan. The alliance will provide comprehensive services and commercial power utilities to the Japanese government for decommissioning their reactors and nuclear facilities.
AECOM’s Share Price Performance
The company’s shares have gained 32.7%, comparing favorably with its industry’s rally of 18.3% in the year-to-date period. Earnings estimates have been trending upward over the past 30 days, reflecting optimism surrounding the stock. The company's endeavors to improve profitability and de-risk its business profile by focusing more on the fastest-growing markets having more competitive advantages are expected to drive growth.
Altair Engineering, KBR and Quanta Services’ earnings for the current year are expected to grow 53.7%, 8.5%, and 29.5%, respectively.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +98%, +119% and +164% in as little as 1 month. The stocks in this report could perform even better.
Image: Bigstock
AECOM (ACM) to Spin Off Government Services Unit, Shares Up
AECOM (ACM - Free Report) announced that the board of directors has approved a plan to spin off the Management Services (“MS”) line of business into a separate government services company. The transaction, which is expected to be completed by the second half of fiscal 2020, will position AECOM’s industry-leading businesses for long-term strategic and financial growth. Notably, the company’s shares jumped more than 5% post the announcement of the news.
.jpg)
Benefits From This Transformational Initiative
The spin-off is part of AECOM’s ongoing transformational initiatives. It has been undertaking various strategic actions, including $225-million General and Administrative (G&A) reduction plan, to maximize shareholder value. It has initiated plans of exiting hard-bid at-risk construction and non-core Oil & Gas and fixed-price combined-cycle gas power plant construction businesses. Also, it has contemplated exit from more than 30 countries and to no longer pursue international at-risk construction opportunities.
Post the spin-off, AECOM is expected to benefit from high-returning professional services businesses, strong cash flow, solid return of capital to its shareholders and debt reduction under the existing capital allocation policy.
Per the plan, both the companies are likely to benefit from strong management teams, with primary focus on their respective businesses, and separate boards of directors’ proficiency.
the company revealed that the new public company will be ranked among top 20 government service providers, as ranked by Bloomberg. The new entity will continue to leverage its extensive intelligence, cybersecurity, IT, nuclear remediation and O&M expertise to provide value and best-of-class services, primarily to various government agencies.
The company will be well placed to execute strategic plans for expanding its capabilities and pursuing more than $30 billion pipeline of opportunities. The business will be fortified with several key competitive advantages, including scale in a fragmented market, strong execution of pipeline contracts, and more than 25,000 talented and committed employees.
AECOM Inks Agreement With Toshiba; Fortifies MS Business
In a separate release, AECOM unveiled that it has signed an Alliance Agreement with Toshiba to work together on decommissioning nuclear reactors in Japan. The alliance will provide comprehensive services and commercial power utilities to the Japanese government for decommissioning their reactors and nuclear facilities.
AECOM’s Share Price Performance
The company’s shares have gained 32.7%, comparing favorably with its industry’s rally of 18.3% in the year-to-date period. Earnings estimates have been trending upward over the past 30 days, reflecting optimism surrounding the stock. The company's endeavors to improve profitability and de-risk its business profile by focusing more on the fastest-growing markets having more competitive advantages are expected to drive growth.
Zacks Rank & Other Key Picks
Currently, AECOM carries a Zacks Rank #2 (Buy). Other top-ranked stocks in the same space include Altair Engineering Inc. (ALTR - Free Report) , KBR, Inc. (KBR - Free Report) and Quanta Services, Inc. (PWR - Free Report) , each holding a Zacks Rank #2. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Altair Engineering, KBR and Quanta Services’ earnings for the current year are expected to grow 53.7%, 8.5%, and 29.5%, respectively.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +98%, +119% and +164% in as little as 1 month. The stocks in this report could perform even better.
See these 7 breakthrough stocks now>>